APMD Company Profile and Key Details

Average 10-day trading volume of 392.52 thousand shares is in line with the 3-month average of 390.58 thousand, indicating normal recent market interest.

Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $50.00 to $50.00. The high target offers 79.66% upside. The low target suggests 79.66% downside. The mean target is $50.00. This offers 79.66% upside.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Apnimed, Inc. (NASDAQ:APMD) closed at $27.83 USD, gaining $0.98 (3.65%) from the previous close of $26.85. The stock is currently mid-range between its 52-week high and low $16.12 and $35.29. With a market capitalization of about $1.11 billion, Apnimed, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 528.94 thousand shares, volume is running light vs its 52-week average. Headquartered in Cambridge, MA, Apnimed, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Kevin R. Lind, the company employs approximately 65 people and listed since July 29, 2026. Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets.

Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $50.00, suggesting 79.66% upside. Our AI forecast model points to short-term strength (4.38% over two weeks), a medium-term fall (-38.77% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Apnimed, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.38%, with price expected at $29.05 by September 16, 2026, within a range of $26.57 to $31.54 3-Month Outlook: Projected fall of -38.77%, reaching $17.04 by November 30, 2026, with a range of $16.81 to $17.28. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by September 02, 2027, within a range of $0.00 to $0.00.